Coexpression cluster:C1147

Full id: C1147_Mesenchymal_Renal_Alveolar_Fibroblast_Placental_Pericytes_Hepatic

Phase1 CAGE Peaks

Hg19::chr11:64851666..64851728,+	p1@ZFPL1
Hg19::chr11:66056596..66056622,-	p1@YIF1A
Hg19::chr19:11039271..11039355,-	p1@YIPF2
Hg19::chr19:38806561..38806607,-	p1@YIF1B
Hg19::chr1:44444865..44444930,+	p1@B4GALT2
Hg19::chr5:180229833..180229860,-	p3@MGAT1
Hg19::chr6:43484621..43484706,-	p1@YIPF3

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0016021	integral to membrane	0.000580518378430204
GO:0031224	intrinsic to membrane	0.000580518378430204
GO:0044425	membrane part	0.00101525068808855
GO:0030133	transport vesicle	0.00171329991318636
GO:0016020	membrane	0.0031001539715636
GO:0005794	Golgi apparatus	0.00453665188376353
GO:0008194	UDP-glycosyltransferase activity	0.00470395734307677
GO:0003831	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity	0.00666117273112001
GO:0004461	lactose synthase activity	0.00666117273112001
GO:0044444	cytoplasmic part	0.00722897183027535
GO:0003945	N-acetyllactosamine synthase activity	0.00726609217133451
GO:0003827	alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity	0.00832499538422828
GO:0016758	transferase activity, transferring hexosyl groups	0.0103938426317109
GO:0043231	intracellular membrane-bound organelle	0.0108150443212596
GO:0043227	membrane-bound organelle	0.0108150443212596
GO:0016023	cytoplasmic membrane-bound vesicle	0.0123942685714032
GO:0031988	membrane-bound vesicle	0.0123942685714032
GO:0000139	Golgi membrane	0.0125714635726644
GO:0044431	Golgi apparatus part	0.0147521770957566
GO:0031410	cytoplasmic vesicle	0.0147521770957566
GO:0031982	vesicle	0.0147521770957566
GO:0016757	transferase activity, transferring glycosyl groups	0.0147521770957566
GO:0035250	UDP-galactosyltransferase activity	0.0147521770957566
GO:0006023	aminoglycan biosynthetic process	0.0174578072166668
GO:0043229	intracellular organelle	0.0192729000207756
GO:0043226	organelle	0.0192729000207756
GO:0005737	cytoplasm	0.0260771053646539
GO:0008378	galactosyltransferase activity	0.0284547695479466
GO:0005793	ER-Golgi intermediate compartment	0.0295262676453299
GO:0008375	acetylglucosaminyltransferase activity	0.0298643231755696
GO:0006022	aminoglycan metabolic process	0.0319533690155563
GO:0005975	carbohydrate metabolic process	0.0319533690155563
GO:0006487	protein amino acid N-linked glycosylation	0.0319533690155563
GO:0044424	intracellular part	0.0413708282874496
GO:0012505	endomembrane system	0.0481188913306716

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n

Uber Anatomy

Ontology term	p-value	n

Disease

Ontology term	p-value	n

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.